Tadesse, Tesfaye Yimer
Kifle, Zemene Demelash
Adugna, Meaza
Fisiha, Betelhem
Teshager, Tefera
Ashagrie, Mulugeta
Yesuf, Jibril Seid
Article History
Received: 17 January 2025
Accepted: 9 June 2025
First Online: 1 July 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the School of Pharmacy, College of Medicine and Health Science, University of Gondar, with the approval number of SOP/257/2022. Oral informed consent was obtained from each participant before the interview. The purpose of the study and the informed consent process were clearly explained to participants both verbally and in written form. Participants were assured of their right to withdraw from the study at any time without any obligation to the research team. No incentives or rewards were provided for participation. The confidentiality of all participants was strictly maintained.
: Not applicable.
: The authors declare no competing interests.